Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta-analysis.
Takeo YoshiharaShinichiro ShinzakiTakahiro AmanoHideki IijimaTetsuo TakeharaNagamu InoueMotoi UchinoMotohiro EsakiTaku KobayashiMasayuki SarutaKen SugimotoShiro NakamuraKeisuke HataFumihito HiraiSakiko HiraokaToshimitsu FujiiMinoru MatsuuraKatsuyoshi MatsuokaKenji WatanabeHiroshi NakaseMamoru WatanabePublished in: Journal of gastroenterology and hepatology (2021)
The efficacy of concomitant use of an IM with UST as an induction therapy for CD was significantly superior to that of monotherapy with UST.